Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma?

被引：0

作者：

Rottmann, Douglas ^{[1
]}

Matsumoto, Nana ^{[2
]}

Assem, Hisham ^{[3
]}

Wong, Serena ^{[2
]}

Hui, Pei ^{[4
]}

Buza, Natalia ^{[4
]}

机构：

[1] Yale Sch Med, Hamden, CT USA

[2] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA

[3] Yale Sch Med, New Haven, CT USA

[4] Yale Univ, Sch Med, New Haven, CT USA

来源：

LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1179

引用

页码：1126 / 1126

页数：1

共 50 条

[21] HER2 Immunohistochemistry Significantly Overestimates HER2 Amplification in Uterine Papillary Serous Carcinoma
Mentrikoski, M. J.
Stowman, A.
Stoler, M. H.
MODERN PATHOLOGY, 2014, 27 : 296A - 296A
[22] HER2 Immunohistochemistry Significantly Overestimates HER2 Amplification in Uterine Papillary Serous Carcinoma
Mentrikoski, M. J.
Stowman, A.
Stoler, M. H.
LABORATORY INVESTIGATION, 2014, 94 : 296A - 296A
[23] Evaluation of HER2 in Endometrial Serous Carcinomas: Is there a role for a HER2-Low Subgroup?
Jou, David
Hecht, Jonathan
Quintana, Liza
Lepe, Marcos
LABORATORY INVESTIGATION, 2023, 103 (03) : S923 - S924
[24] Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?
Lee, Andrew H. S.
Hodi, Zsolt
Abbas, Areeg
Wencyk, Peter
Ellis, Ian O.
Rakha, Emad
JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (11) : 726 - 729
[25] HER2 Testing in Endometrial Serous Carcinoma Time for Standardized Pathology Practice to Meet the Clinical Demand
Buza, Natalia
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 687 - 691
[26] Evaluating HER2 status using HER2 Gene Protein Assay in Endometrial Cancer
Shafi, Saba
Parwani, Anil
Li, Zaibo
Nitta, Hiro
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 824 - 825
[27] Evaluating HER2 status using HER2 Gene Protein Assay in Endometrial Cancer
Shafi, Saba
Parwani, Anil
Li, Zaibo
Nitta, Hiro
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 824 - 825
[28] EGFR and HER2/neu expression in stage matched type 1 and type 2 endometrial carcinoma
Gowda, V.
Logani, S.
LABORATORY INVESTIGATION, 2007, 87 : 199A - 199A
[29] EGFR and HER2/neu expression in stage matched type 1 and type 2 endometrial carcinoma
Gowda, V.
Logani, S.
MODERN PATHOLOGY, 2007, 20 : 199A - 199A
[30] Frequent Discordant HER2 Status Between Primary and Metastatic Endometrial Serous Carcinomas in the Setting of Targeted Therapy
Maruthi, Vijaya Kadam
Niu, Na
Hui, Pei
Buza, Natalia
LABORATORY INVESTIGATION, 2024, 104 (03) : S1174 - S1175

← 1 2 3 4 5 →